IL2 and cancer: Both IL-2/anti-IL-2 and IL-15/IL-15RαFc complexes have been shown to boost NK cell and memory CD8+ T cell numbers in mice and to enhance their cytolytic capacity against viral-infected and cancer cells [16, 18–20].